In a significant move poised to accelerate the development of novel cancer therapies, Novartis has entered into a strategic collaboration…
Read More
Insilico CEO sees potentially $2.75 billion collaboration as ‘fusing Lilly’s clinical excellence’ with Insilico’s ‘end-to-end AI engine’
A transformative partnership has been forged between Insilico Medicine, a pioneer in artificial intelligence-driven drug discovery, and Eli Lilly, a…
Read More
Pfizer and Innovent Biologics Announce Landmark Global Collaboration for Oncology Pipeline, Valued Up to $10.5 Billion
In a significant move poised to accelerate the development of novel cancer treatments, global pharmaceutical giant Pfizer and leading Chinese…
Read More
Regeneron Pharmaceuticals and Parabilis Medicines Forge Landmark $2.32 Billion Collaboration to Pioneer a New Era of Intracellular Therapies
Regeneron Pharmaceuticals has announced a monumental research collaboration with Parabilis Medicines, a deal valued at an impressive $2.32 billion. This…
Read More
Insilico CEO sees potentially $2.75 billion collaboration as ‘fusing Lilly’s clinical excellence’ with Insilico’s ‘end-to-end AI engine’
In a landmark move poised to reshape the landscape of pharmaceutical innovation, Insilico Medicine, a pioneer in artificial intelligence (AI)-driven…
Read More
Bristol Myers Squibb and Hengrui Pharma Forge Landmark $15.2 Billion Oncology and Immunology Collaboration
Bristol Myers Squibb (BMS) and Chinese biopharmaceutical giant Hengrui Pharma have announced a monumental licensing and collaboration agreement, potentially valued…
Read More
Insilico CEO Sees Potentially $2.75 Billion Collaboration as ‘Fusing Lilly’s Clinical Excellence’ with Insilico’s ‘End-to-End AI Engine’
On March 29, Insilico Medicine, a pioneer in artificial intelligence (AI)-driven drug discovery and development, announced a landmark collaboration with…
Read More
Insilico CEO Sees Potentially $2.75 Billion Collaboration as Fusing Lilly’s Clinical Excellence with Insilico’s End-to-End AI Engine
On March 29, Insilico Medicine, a pioneer in artificial intelligence (AI)-driven drug discovery and development, announced a monumental drug discovery…
Read More
Insilico CEO sees potentially $2.75 billion collaboration as ‘fusing Lilly’s clinical excellence’ with Insilico’s ‘end-to-end AI engine’
Insilico Medicine, a pioneering company in artificial intelligence-driven drug discovery and development, has cemented a landmark global research and development…
Read More
Boehringer Ingelheim and Zai Lab Forge Clinical Collaboration to Pioneer Novel Combination Therapy for Aggressive Lung Cancers
Boehringer Ingelheim and Zai Lab have announced a significant clinical collaboration aimed at investigating a dual delta-like ligand 3 (DLL3)-targeting…
Read More
